Logo image of GEVO

GEVO INC (GEVO) Stock Fundamental Analysis

USA - NASDAQ:GEVO - US3743964062 - Common Stock

2.61 USD
+0.14 (+5.67%)
Last: 10/20/2025, 8:00:01 PM
2.6 USD
-0.01 (-0.38%)
Pre-Market: 10/21/2025, 5:31:40 AM
Fundamental Rating

2

GEVO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 211 industry peers in the Oil, Gas & Consumable Fuels industry. While GEVO seems to be doing ok healthwise, there are quite some concerns on its profitability. GEVO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GEVO has reported negative net income.
GEVO had a negative operating cash flow in the past year.
In the past 5 years GEVO always reported negative net income.
In the past 5 years GEVO always reported negative operating cash flow.
GEVO Yearly Net Income VS EBIT VS OCF VS FCFGEVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

GEVO has a Return On Assets of -8.31%. This is amonst the worse of the industry: GEVO underperforms 81.99% of its industry peers.
With a Return On Equity value of -12.31%, GEVO is not doing good in the industry: 72.99% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.31%
ROE -12.31%
ROIC N/A
ROA(3y)-12.55%
ROA(5y)-14.65%
ROE(3y)-14.71%
ROE(5y)-16.48%
ROIC(3y)N/A
ROIC(5y)N/A
GEVO Yearly ROA, ROE, ROICGEVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 41.27%, GEVO is in line with its industry, outperforming 50.24% of the companies in the same industry.
GEVO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GEVO Yearly Profit, Operating, Gross MarginsGEVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

4

2. Health

2.1 Basic Checks

GEVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GEVO has been reduced compared to 1 year ago.
GEVO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, GEVO has a worse debt to assets ratio.
GEVO Yearly Shares OutstandingGEVO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
GEVO Yearly Total Debt VS Total AssetsGEVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

GEVO has an Altman-Z score of 0.08. This is a bad value and indicates that GEVO is not financially healthy and even has some risk of bankruptcy.
GEVO has a Altman-Z score of 0.08. This is in the lower half of the industry: GEVO underperforms 68.25% of its industry peers.
GEVO has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
GEVO has a better Debt to Equity ratio (0.29) than 61.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z 0.08
ROIC/WACCN/A
WACC7.99%
GEVO Yearly LT Debt VS Equity VS FCFGEVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

GEVO has a Current Ratio of 2.33. This indicates that GEVO is financially healthy and has no problem in meeting its short term obligations.
GEVO has a better Current ratio (2.33) than 79.15% of its industry peers.
A Quick Ratio of 2.10 indicates that GEVO has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.10, GEVO is doing good in the industry, outperforming 78.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.33
Quick Ratio 2.1
GEVO Yearly Current Assets VS Current LiabilitesGEVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.75% over the past year.
GEVO shows a strong growth in Revenue. In the last year, the Revenue has grown by 341.75%.
The Revenue has been decreasing by -7.13% on average over the past years.
EPS 1Y (TTM)18.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
Revenue 1Y (TTM)341.75%
Revenue growth 3Y217.2%
Revenue growth 5Y-7.13%
Sales Q2Q%725.34%

3.2 Future

GEVO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.84% yearly.
The Revenue is expected to grow by 72.79% on average over the next years. This is a very strong growth
EPS Next Y30.74%
EPS Next 2Y18.64%
EPS Next 3Y12.32%
EPS Next 5Y29.84%
Revenue Next Year1007.55%
Revenue Next 2Y250.85%
Revenue Next 3Y133.2%
Revenue Next 5Y72.79%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GEVO Yearly Revenue VS EstimatesGEVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
GEVO Yearly EPS VS EstimatesGEVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -1K -2K -3K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GEVO. In the last year negative earnings were reported.
Also next year GEVO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GEVO Price Earnings VS Forward Price EarningsGEVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GEVO Per share dataGEVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as GEVO's earnings are expected to grow with 12.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.64%
EPS Next 3Y12.32%

More info and screens

0

5. Dividend

5.1 Amount

GEVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GEVO INC

NASDAQ:GEVO (10/20/2025, 8:00:01 PM)

Premarket: 2.6 -0.01 (-0.38%)

2.61

+0.14 (+5.67%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners30.75%
Inst Owner Change4.11%
Ins Owners4.12%
Ins Owner Change1.91%
Market Cap631.20M
Analysts78
Price Target2.04 (-21.84%)
Short Float %16.63%
Short Ratio5.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)62.24%
Min EPS beat(2)7.12%
Max EPS beat(2)117.35%
EPS beat(4)2
Avg EPS beat(4)14.32%
Min EPS beat(4)-49.55%
Max EPS beat(4)117.35%
EPS beat(8)2
Avg EPS beat(8)-5.34%
EPS beat(12)2
Avg EPS beat(12)-27.13%
EPS beat(16)3
Avg EPS beat(16)-20.04%
Revenue beat(2)1
Avg Revenue beat(2)19.02%
Min Revenue beat(2)-8.38%
Max Revenue beat(2)46.42%
Revenue beat(4)2
Avg Revenue beat(4)3.65%
Min Revenue beat(4)-64.45%
Max Revenue beat(4)46.42%
Revenue beat(8)4
Avg Revenue beat(8)3.29%
Revenue beat(12)6
Avg Revenue beat(12)-6.26%
Revenue beat(16)7
Avg Revenue beat(16)-11.79%
PT rev (1m)22.45%
PT rev (3m)-58.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.18%
EPS NY rev (1m)1.38%
EPS NY rev (3m)3.39%
Revenue NQ rev (1m)18.77%
Revenue NQ rev (3m)-11.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.87
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.75
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.33
BVpS1.96
TBVpS1.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.31%
ROE -12.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.27%
FCFM N/A
ROA(3y)-12.55%
ROA(5y)-14.65%
ROE(3y)-14.71%
ROE(5y)-16.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 158.24%
Cap/Sales 44.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.33
Quick Ratio 2.1
Altman-Z 0.08
F-Score5
WACC7.99%
ROIC/WACCN/A
Cap/Depr(3y)508.76%
Cap/Depr(5y)546.58%
Cap/Sales(3y)2347.16%
Cap/Sales(5y)3571.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
EPS Next Y30.74%
EPS Next 2Y18.64%
EPS Next 3Y12.32%
EPS Next 5Y29.84%
Revenue 1Y (TTM)341.75%
Revenue growth 3Y217.2%
Revenue growth 5Y-7.13%
Sales Q2Q%725.34%
Revenue Next Year1007.55%
Revenue Next 2Y250.85%
Revenue Next 3Y133.2%
Revenue Next 5Y72.79%
EBIT growth 1Y45.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year98.48%
EBIT Next 3Y33.25%
EBIT Next 5Y25.32%
FCF growth 1Y25.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.9%
OCF growth 3YN/A
OCF growth 5YN/A